BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, Gratwohl A, Madrigal A, Niederwieser D, Passweg J. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006;37:439-449. [PMID: 16444286 DOI: 10.1038/sj.bmt.1705265] [Cited by in Crossref: 145] [Cited by in F6Publishing: 165] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Moghassemi S, Dadashzadeh A, de Azevedo RB, Amorim CA. Secure transplantation by tissue purging using photodynamic therapy to eradicate malignant cells. J Photochem Photobiol B 2022;234:112546. [PMID: 36029759 DOI: 10.1016/j.jphotobiol.2022.112546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Godoy MC, Ferreira Dalla Pria HR, Truong MT, Shroff GS, Marom EM. Invasive Fungal Pneumonia in Immunocompromised Patients. Radiologic Clinics of North America 2022;60:497-506. [DOI: 10.1016/j.rcl.2022.01.006] [Reference Citation Analysis]
3 Vucinic V, Jentzsch M, Leiblein S, Bach E, Remane Y, Schulze-Forster K, Cross M, Pönisch W, Schwind S, Franke GN, Platzbecker U, Niederwieser D. Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39). Transfusion 2021. [PMID: 34893987 DOI: 10.1111/trf.16761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Revels JW, Fadl SA, Wang SS, Ladumor H, Xu H, Kicska G. Imaging features of fungal pneumonia in haematopoietic stem cell transplant patients. Pol J Radiol 2021;86:e335-43. [PMID: 34322182 DOI: 10.5114/pjr.2021.107057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zahnreich S, Schmidberger H. Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies. Cancers (Basel) 2021;13:2607. [PMID: 34073340 DOI: 10.3390/cancers13112607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Mckenna DH, Stroncek DF. Cellular Engineering. Transfusion Medicine 2021. [DOI: 10.1002/9781119599586.ch19] [Reference Citation Analysis]
7 Berg BB, Soares JS, Paiva IR, Rezende BM, Rachid MA, Cau SBA, Romero TRL, Pinho V, Teixeira MM, Castor MGME. Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response. J Pharmacol Exp Ther 2021;377:273-83. [PMID: 33658314 DOI: 10.1124/jpet.120.000479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Barban JB, Simões BP, Moraes BDGC, Anunciação CRD, Rocha CSD, Pintor DCQ, Guerra DC, Silva DA, Brandão ECM, Kerbauy F, Pires FRO, Morais GL, Schmidt Filho J, Sicchieri JMF, Barroso KSN, Viana LV, Rocha MHMD, Guimarães MP, Lazzari NLC, Hamerschlak N, Ramos P, Gomes PN, Mendonça PDS, Oliveira RC, Scomparim RC, Chiattone R, Diez-Garcia RW, Cardenas TC, Miola TM, Costa TCM, Rocha V, Pereira AZ. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Adults.Einstein (Sao Paulo). 2020;18:AE4530. [PMID: 32049129 DOI: 10.31744/einstein_journal/2020AE4530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Gui RR, Zu YL, Zhang Y, Han LJ, Zhao HF, Li Z, Yu FK, Wang J, Zhao JJ, Fu YW, Song YP, Zhou J. [Successful treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocytes infusion: three cases report and literatures review]. Zhonghua Xue Ye Xue Za Zhi 2019;40:333-5. [PMID: 31104448 DOI: 10.3760/cma.j.issn.0253-2727.2019.04.014] [Reference Citation Analysis]
10 Zaucha-Prażmo A, Sadurska E, Pieczonka A, Goździk J, Dębski R, Drabko K, Zawitkowska J, Lejman M, Wachowiak J, Styczyński J, Kowalczyk JR. Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation. Ann Transplant 2019;24:374-82. [PMID: 31235684 DOI: 10.12659/AOT.915330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hirose EY, de Molla VC, Gonçalves MV, Pereira AD, Szor RS, da Fonseca ARBM, Fatobene G, Serpa MG, Xavier EM, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C. The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes. Clin Nutr ESPEN 2019;33:213-9. [PMID: 31451264 DOI: 10.1016/j.clnesp.2019.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Boruczkowski D, Pujal JM, Zdolińska-Malinowska I. Autologous cord blood in children with cerebral palsy: a review. Int J Mol Sci 2019;20:E2433. [PMID: 31100943 DOI: 10.3390/ijms20102433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kumar A, D'Souza SS, Thakur AS. Understanding the Journey of Human Hematopoietic Stem Cell Development. Stem Cells Int 2019;2019:2141475. [PMID: 31198425 DOI: 10.1155/2019/2141475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
14 Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR, Kuball J, Lankester AC, Lanza F, Montoto S, Nagler A, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant 2019;54:1525-52. [PMID: 30953028 DOI: 10.1038/s41409-019-0516-2] [Cited by in Crossref: 148] [Cited by in F6Publishing: 154] [Article Influence: 37.0] [Reference Citation Analysis]
15 Kriegsmann K, Wuchter P. Mobilization and Collection of Peripheral Blood Stem Cells in Adults: Focus on Timing and Benchmarking. Methods Mol Biol 2019;2017:41-58. [PMID: 31197767 DOI: 10.1007/978-1-4939-9574-5_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Rein LA, Yang H, Chao NJ. Applications of Gene Editing Technologies to Cellular Therapies. Biology of Blood and Marrow Transplantation 2018;24:1537-45. [DOI: 10.1016/j.bbmt.2018.03.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Kriegsmann K, Schmitt A, Kriegsmann M, Bruckner T, Anyanwu A, Witzens-Harig M, Müller-Tidow C, Klein S, Wuchter P. Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.Biol Blood Marrow Transplant. 2018;24:1281-1288. [PMID: 29353110 DOI: 10.1016/j.bbmt.2018.01.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
18 Baertsch MA, Kriegsmann K, Pavel P, Bruckner T, Hundemer M, Kriegsmann M, Ho AD, Goldschmidt H, Wuchter P. Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result.Transfus Med Hemother. 2018;45:24-31. [PMID: 29593457 DOI: 10.1159/000478911] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Sinatora F, Traverso A, Zanato S, Di Florio N, Porreca A, Tremolada M, Boscolo V, Marzollo A, Mainardi C, Calore E, Pillon M, Cattelan C, Basso G, Messina C. Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis. Front Psychol 2017;8:1316. [PMID: 28848462 DOI: 10.3389/fpsyg.2017.01316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
20 Nuernberg MAA, Rodrigues SC, Perdoncini NN, Funke VAM, Bonfim CMS, Nabhan SK, Torres-pereira CC. Periodontal status of candidates for allogeneic hematopoietic stem cell transplantation: PERIODONTAL DISEASE IN TRANSPLANT CANDIDATES. Spec Care Dentist 2017;37:187-93. [DOI: 10.1111/scd.12229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Hernández-Fernández A, Ortiz-Ruiz AJ, De Arriba-de la Fuente F, Vicente-García V, Iniesta-López-Matencio P, Oñate-Sánchez RE. Cambra system in patients awaiting hematopoietic progenitor cell transplant and high caries risk. J Clin Exp Dent 2017;9:e654-60. [PMID: 28512542 DOI: 10.4317/jced.53617] [Reference Citation Analysis]
22 Cellular Engineering for the Production of New Blood Components. Transfusion Medicine 2016. [DOI: 10.1002/9781119236504.ch18] [Reference Citation Analysis]
23 Kizilbash SJ, Kashtan CE, Chavers BM, Cao Q, Smith AR. Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016;22:1264-70. [PMID: 27034153 DOI: 10.1016/j.bbmt.2016.03.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
24 Bell D, Knipe H. Haematopoietic stem cell transplantation. Radiopaedia.org 2016. [DOI: 10.53347/rid-43034] [Reference Citation Analysis]
25 Patir P, Vural F. Treatment of mycosis fungoides, in the era of stem cell transplantation. World J Dermatol 2016; 5(1): 52-56 [DOI: 10.5314/wjd.v5.i1.52] [Reference Citation Analysis]
26 Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D'Agostino RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 2016;127:1656-65. [PMID: 26825712 DOI: 10.1182/blood-2015-10-676924] [Cited by in Crossref: 190] [Cited by in F6Publishing: 201] [Article Influence: 27.1] [Reference Citation Analysis]
27 Mutlu D, Uygun V, Yazisiz H, Tezcan G, Hazar V, Colak D. Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation. Ann Saudi Med 2014;34:6-11. [PMID: 24658548 DOI: 10.5144/0256-4947.2014.6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Batorov EV, Shevela EY, Tikhonova MA, Batorova DS, Ushakova GY, Sizikova SA, Sergeevicheva VV, Gilevich AV, Kryuchkova IV, Ostanin AA, Chernykh ER. Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas. Cell Immunol 2015;297:80-6. [PMID: 26227214 DOI: 10.1016/j.cellimm.2015.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
29 Rockstroh A, Al-ali HK, Lange T, Pönisch W, Krahl R, Cross M, Behre G, Niederwieser D, Pfrepper C. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation. J Cancer Res Clin Oncol 2015;141:2193-203. [DOI: 10.1007/s00432-015-2003-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Lin S, Zhao R, Xiao Y, Li P. Mechanisms determining the fate of hematopoietic stem cells. Stem Cell Investig 2015;2:10. [PMID: 27358878 DOI: 10.3978/j.issn.2306-9759.2015.05.01] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
31 Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Marsh JC, Nagler A, Peters C, Velardi A, Mohty M, Madrigal A. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant 2015;50:1037-56. [PMID: 25798672 DOI: 10.1038/bmt.2015.6] [Cited by in Crossref: 218] [Cited by in F6Publishing: 237] [Article Influence: 27.3] [Reference Citation Analysis]
32 Danel Buhl N, Seguy D. Nutritional Support in Adult Patients Undergoing Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning. Diet and Nutrition in Critical Care 2015. [DOI: 10.1007/978-1-4614-7836-2_152] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Hsu SN, Chen JH, Kao WY. Allogeneic hematopoietic stem cell transplantation as the first-line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report. Oncol Lett 2014;8:1831-3. [PMID: 25202420 DOI: 10.3892/ol.2014.2341] [Reference Citation Analysis]
34 Zaleska-Dorobisz U, Biel A, Sokołowska-Dąbek D, Olchowy C, Łasecki M. Ultrasonography in the diagnosis of hemorrhagic cystitis - a complication of bone marrow transplantation in pediatric oncology patients. J Ultrason 2014;14:258-72. [PMID: 26675710 DOI: 10.15557/JoU.2014.0026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
35 Wellman SS, Ledford C, Vap AR. Total Hip Arthroplasty in Very Young Bone Marrow Transplant Patients. The Duke Orthopaedic Journal 2014;4:19-23. [DOI: 10.5005/jp-journals-10017-1044] [Reference Citation Analysis]
36 Mariani M, Colombo F, Assennato SM, Frugoni C, Cattaneo A, Trombetta E, Rebulla P, Porretti L. Evaluation of an easy and affordable flow cytometer for volumetric haematopoietic stem cell counting. Blood Transfus 2014;12:416-20. [PMID: 24887218 DOI: 10.2450/2014.0198-13] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
37 Edwards NE, Ellingwood A, Hebdon M, Foli KJ, Freeman JL. Guiding Patient Decision-Making Regarding Bone Marrow Donation. The Journal for Nurse Practitioners 2014;10:113-119. [DOI: 10.1016/j.nurpra.2013.08.019] [Reference Citation Analysis]
38 Hequet O, Le QH, Rodriguez J, Dubost P, Revesz D, Clerc A, Rigal D, Salles G, Coiffier B. Development of model for analysing respective collections of intended hematopoietic stem cells and harvests of unintended mature cells in apheresis for autologous hematopoietic stem cell collection. Transfus Apher Sci 2014;50:294-302. [PMID: 24462181 DOI: 10.1016/j.transci.2013.12.014] [Reference Citation Analysis]
39 Annaloro C, Airaghi L, Saporiti G, Onida F, Cortelezzi A, Deliliers GL. Metabolic syndrome in patients with hematological diseases. Expert Review of Hematology 2014;5:439-58. [DOI: 10.1586/ehm.12.35] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
40 Buhl ND, Seguy D. Nutritional Support in Adult Patients Undergoing Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning. Diet and Nutrition in Critical Care 2014. [DOI: 10.1007/978-1-4614-8503-2_152-1] [Reference Citation Analysis]
41 Vargas AO, Luna RR, Garcia MP, Cardos RC, Hidalgo LV, Jácome DL, Gutiérrez MC. Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation. Rev Bras Hematol Hemoter 2013;35:343-6. [PMID: 24255618 DOI: 10.5581/1516-8484.20130099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
42 Urbano-ispizua A, Baldomero H, Gratwohl A. Hematopoietic stem cell transplantation in Europe. Differences between Eastern and Western countries. Hematology 2012;17:s192-4. [DOI: 10.1179/102453312x13336169157095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 Gladysz D, Pawelec K, Baran J, Boruczkowski D. Stem cell transplantations – Famicord Group own experience. JCOT 2013;1:35-38. [DOI: 10.22494/cot.v1i1.43] [Reference Citation Analysis]
44 Tripura C, Pande G. Applications of human hematopoietic stem cells isolated and expanded from different tissues in regenerative medicine. Regenerative Medicine 2013;8:783-95. [DOI: 10.2217/rme.13.75] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
45 Perrier L, Lefranc A, Pérol D, Quittet P, Schmidt-Tanguy A, Siani C, de Peretti C, Favier B, Biron P, Moreau P, Bay JO, Lissandre S, Jardin F, Espinouse D, Sebban C. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial. Appl Health Econ Health Policy 2013;11:129-38. [PMID: 23435861 DOI: 10.1007/s40258-013-0011-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
46 Sobol U, Rodriguez T, Smith S, Go A, Vimr R, Parthasarathy M, Guo R, Stiff P. Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease. Leuk Lymphoma 2014;55:1281-7. [PMID: 23987822 DOI: 10.3109/10428194.2013.838233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
47 Bryant A, Nivison-smith I, Pillai ES, Kennedy G, Kalff A, Ritchie D, George B, Hertzberg M, Patil S, Spencer A, Fay K, Cannell P, Berkahn L, Doocey R, Spearing R, Moore J. Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients. Bone Marrow Transplant 2014;49:17-23. [DOI: 10.1038/bmt.2013.142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
48 Mosevoll KA, Akkök ÇA, Hervig T, Melve GK, Bruserud Ø, Reikvam H. Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy 2013;15:850-60. [DOI: 10.1016/j.jcyt.2013.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
49 Garcia MC, Chapman JR, Shaw PJ, Gottlieb DJ, Ralph A, Craig JC, Tong A. Motivations, Experiences, and Perspectives of Bone Marrow and Peripheral Blood Stem Cell Donors: Thematic Synthesis of Qualitative Studies. Biology of Blood and Marrow Transplantation 2013;19:1046-58. [DOI: 10.1016/j.bbmt.2013.04.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
50 Veljković D, Nonković OŠ, Radonjić Z, Kuzmanović M, Zečević Z. Bone marrow processing for transplantation using Cobe Spectra cell separator. Transfus Apher Sci 2013;48:359-63. [PMID: 23628356 DOI: 10.1016/j.transci.2013.04.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
51 Sproull M, Avondoglio D, Kramp T, Shankavaram U, Camphausen K. Correlation of plasma FL expression with bone marrow irradiation dose. PLoS One 2013;8:e58558. [PMID: 23505536 DOI: 10.1371/journal.pone.0058558] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
52 Uçkan D. Pediatric Diseases and Stem Cells: Recent Advances and Challenges. Stem Cells: Current Challenges and New Directions 2013. [DOI: 10.1007/978-1-4614-8066-2_7] [Reference Citation Analysis]
53 Corbacioglu S, Kernan N, Lehmann L, Brochstein J, Revta C, Grupp S, Martin P, Richardson PG. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Expert Rev Hematol 2012;5:291-302. [PMID: 22780209 DOI: 10.1586/ehm.12.18] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
54 Kramer M, Heussner P, Herzberg PY, Andree H, Hilgendorf I, Leithaeuser M, Junghanss C, Freund M, Wolff D. Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation. Support Care Cancer 2013;21:1121-9. [DOI: 10.1007/s00520-012-1634-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
55 Seguy D, Duhamel A, Rejeb MB, Gomez E, Buhl ND, Bruno B, Cortot A, Yakoub-agha I. Better Outcome of Patients Undergoing Enteral Tube Feeding After Myeloablative Conditioning for Allogeneic Stem Cell Transplantation. Transplantation 2012;94:287-94. [DOI: 10.1097/tp.0b013e3182558f60] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 7.0] [Reference Citation Analysis]
56 Giebel S, Labopin M, Mohty M, Mufti GJ, Niederwieser D, Cornelissen JJ, Janssen JJ, Milpied N, Vindelov L, Petersen E, Arnold R, Bacigalupo A, Blaise D, Craddock C, Nagler A, Frassoni F, Sadus-Wojciechowska M, Rocha V. The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant 2013;48:238-42. [PMID: 22773125 DOI: 10.1038/bmt.2012.131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
57 Sánchez-Guijo FM, Orfao A, Del Cañizo MC. Bone marrow transplantation extends its scope. Adv Exp Med Biol 2012;741:121-34. [PMID: 22457107 DOI: 10.1007/978-1-4614-2098-9_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
58 Xuan L, Wu X, Wu M, Zhang Y, Liu H, Fan Z, Sun J, Liu Q. Effect of granulocyte colony-stimulating factor mobilization on the expression patterns, clonality and signal transduction of TRAV and TRBV repertoire. Immunobiology 2012;217:816-22. [PMID: 22658922 DOI: 10.1016/j.imbio.2012.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
59 Gutensohn K, Nikolitsis A, Gramatzki M, Spitzer D, Buwitt-Beckmann U, Humpe A. Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells. Transfus Med 2012;22:205-10. [PMID: 22519551 DOI: 10.1111/j.1365-3148.2012.01155.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
60 Szudy A, Litak J, Zawitkowska J, Kowalczyk J. Choroba rozrostowa układu krwiotwórczego u dzieci z zespołem ataksja–teleangiektazja (AT) – trudny problem kliniczny. Acta Haematologica Polonica 2012;43:291-295. [DOI: 10.1016/s0001-5814(12)34007-3] [Reference Citation Analysis]
61 Nowak J, Wachowiak J. Genetic Basis of Donor–Recipient Matching in Allogeneic Transplantation of Hematopoietic Stem Cells. Molecular Aspects of Hematologic Malignancies 2012. [DOI: 10.1007/978-3-642-29467-9_14] [Reference Citation Analysis]
62 McNamara C, Davies J, Dyer M, Hoskin P, Illidge T, Lyttelton M, Marcus R, Montoto S, Ramsay A, Wong WL. Guidelines on the investigation and management of follicular lymphoma. Br J Haematol. 2012;156:446-467. [PMID: 22211428 DOI: 10.1111/j.1365-2141.2011.08969.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
63 . Cellular Engineering for the Production of New Blood Components. Transfusion Medicine 2011. [DOI: 10.1002/9781444398748.ch18] [Reference Citation Analysis]
64 Pession A, Masetti R, Di Leo C, Franzoni M, Prete A. HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors. Pediatr Rep 2011;3 Suppl 2:e12. [PMID: 22053274 DOI: 10.4081/pr.2011.s2.e12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
65 Papamichalis P, Alexiou A, Boulbou M, Dalekos GN, Rigopoulou EI. Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy? Clin Res Hepatol Gastroenterol. 2012;36:84-93. [PMID: 21920838 DOI: 10.1016/j.clinre.2011.07.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
66 Akkök CA, Hervig T, Stamnesfet S, Nesthus I, Melve GK, Lassalle P, Bruserud O. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy 2011;13:1259-68. [PMID: 21905955 DOI: 10.3109/14653249.2011.605117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
67 Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M. Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant 2011;17:1869-73. [PMID: 21771571 DOI: 10.1016/j.bbmt.2011.07.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
68 Shaw SW, David AL, De Coppi P. Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid. Curr Opin Obstet Gynecol. 2011;23:109-116. [PMID: 21386681 DOI: 10.1097/gco.0b013e32834457b1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
69 Kolins JA, Zbylut C, Mccollom S, Aquino VM. Hematopoietic Stem Cell Transplantation in Children. Critical Care Nursing Clinics of North America 2011;23:349-76. [DOI: 10.1016/j.ccell.2011.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
70 Peinemann F, Grouven U, Kröger N, Bartel C, Pittler MH, Lange S. First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia. PLoS One 2011;6:e18572. [PMID: 21541024 DOI: 10.1371/journal.pone.0018572] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
71 Naumann F, Kruse E, Weingart O, Bohlius J, Hübel K, Herrmann-frank A, Skipka G, Engert A. Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia. Cochrane Database of Systematic Reviews 2011. [DOI: 10.1002/14651858.cd006835.pub2] [Reference Citation Analysis]
72 Annaloro C, Onida F, Lambertenghi Deliliers G. Autologous hematopoietic stem cell transplantation in autoimmune diseases. Expert Rev Hematol. 2009;2:699-715. [PMID: 21082959 DOI: 10.1586/ehm.09.60] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
73 Andersson I, Ahlberg K, Stockelberg D, Persson L. Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation: Health-related quality of life after SCT. European Journal of Cancer Care 2011;20:368-79. [DOI: 10.1111/j.1365-2354.2009.01174.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
74 Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Katyal S, Hariprasad R. Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India. Ann Hematol 2011;90:1317-28. [PMID: 21409382 DOI: 10.1007/s00277-011-1205-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
75 Latorre-romero C, Marin-yaseli MR, Belmar-lopez C, del Moral R, Marijuan PC, Quintanilla M, Martin-duque P. Using living cells to transport therapeutic genes for cancer treatment. Clin Transl Oncol 2011;13:10-7. [DOI: 10.1007/s12094-011-0611-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
76 Watt SM, Coldwell K, Smythe J. Comparisons Between Related and Unrelated Cord Blood Collection and/or Banking for Transplantation or Research: The UK NHS Blood and Transplant Experience. Regenerative Medicine Using Pregnancy-Specific Biological Substances 2011. [DOI: 10.1007/978-1-84882-718-9_33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Posch P, Hurley C. Histocompatibility. Blood and Bone Marrow Pathology. Elsevier; 2011. pp. 641-76. [DOI: 10.1016/b978-0-7020-3147-2.00039-0] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
78 Bashir Q, De Lima MJ, McMannis JD, Garcia-Manero G, Shpall E, Kantarjian H, Cortes JE, O'Brien SM, Jones D, Qazilbash M, Wei W, Giralt SA, Champlin RE, Hosing C. Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy. Leuk Lymphoma 2010;51:1478-84. [PMID: 20658954 DOI: 10.3109/10428194.2010.501534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
79 Zinno F, Landi F, Aureli V, Caniglia M, Pinto RM, Rana I, Balduino G, Miele MJ, Picardi A, Arcese W, Isacchi G. Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein’s thawing technique used in 40 transplantation procedures. Transfusion and Apheresis Science 2010;43:173-8. [DOI: 10.1016/j.transci.2010.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
80 Martín-Antonio B, Carmona M, Falantes J, Gil E, Baez A, Suarez M, Marín P, Espigado I, Urbano-Ispizua A. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. Haematologica 2011;96:102-9. [PMID: 20851866 DOI: 10.3324/haematol.2010.026401] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
81 Główka FK, Romański M, Wachowiak J. High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs 2010;19:1275-95. [DOI: 10.1517/13543784.2010.517744] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
82 Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D, Frauendorfer K. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology. Haematologica 2010;95:637-43. [PMID: 20378578 DOI: 10.3324/haematol.2009.015586] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
83 Rodríguez-cortés O, Vela-ojeda J, López-santiago R, Montiel-cervantes L, Reyes-maldonado E, Estrada-garcía I, Moreno-lafont MC. Granulocyte colony-stimulating factor produces a decrease in IFNγ and increase in IL-4 when administrated to healthy donors. J Clin Apheresis 2010;25:181-7. [DOI: 10.1002/jca.20234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
84 Pink R, Vondrakova J, Tvrdy P, Michl P, Pazdera J, Faber E, Skoumalova I, Indrak K. Salivary neutrophils level as an indicator of bone marrow engraftment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009;153:263-9. [PMID: 20208965 DOI: 10.5507/bp.2009.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
85 Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y; Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010;303:1617-24. [PMID: 20424252 DOI: 10.1001/jama.2010.491] [Cited by in Crossref: 460] [Cited by in F6Publishing: 489] [Article Influence: 35.4] [Reference Citation Analysis]
86 Krieger O. Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option? memo 2010;3:16-8. [DOI: 10.1007/s12254-010-0177-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Chinen J, Buckley RH. Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol. 2010;125:S324-S335. [PMID: 20176267 DOI: 10.1016/j.jaci.2009.11.014] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 8.6] [Reference Citation Analysis]
88 Vokurka S, Koza V, Lysak D, Karas M, Dvorak P, Jindra P, Hrabetova M, Vozobulova V. Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patient. J Oncol 2010;2010:460859. [PMID: 20224640 DOI: 10.1155/2010/460859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu D, Tong W, Ghavamzadeh A, Alimoghaddam K, Lie AKW, Liang R, Chan LL, Haipeng L, Tan P, Hwang WYK, Chiou T, Chen P, Van Binh T, Minh NN, Min C, Hwang TJ, Kodera Y; on behalf of Asia-Pacific Blood and Marrow Transplantation Group (APBMT). Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group. Bone Marrow Transplant 2010;45:1682-91. [DOI: 10.1038/bmt.2010.34] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
90 Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S, Fechter M, Greinix H, Koh M, Lee S, Nicoloso-de-faveri G, Philippe J, Pollichieni S, Pulsipher M, Schmidt A, Yang E, van Walraven A; on behalf of the Clinical Working Group and Ethics Working Group of the WMDA. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone Marrow Transplant 2010;45:832-8. [DOI: 10.1038/bmt.2010.2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
91 Ferrá C, Sanz J, de la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM; GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. Biol Blood Marrow Transplant 2010;16:957-66. [PMID: 20144909 DOI: 10.1016/j.bbmt.2010.02.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
92 Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 2009;16:420-6. [PMID: 19680124 DOI: 10.1097/MOH.0b013e328330990f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
93 Schmitz N, Glaß B. Knochenmark- und Blutstammzelltransplantation. Transfusionsmedizin und Immunhämatologie 2010. [DOI: 10.1007/978-3-642-12765-6_32] [Reference Citation Analysis]
94 Gratwohl A, Häusermann P. Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management. Expert Review of Dermatology 2009;4:637-654. [DOI: 10.1586/edm.09.56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
95 Patil S, Spencer A, Schwarer A, Lewis I, Hertzberg M, Avery S, Wei A, Noutsos T, Paul E, Taouk Y, Muirhead J. Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up. Bone Marrow Transplant 2010;45:1154-60. [PMID: 19898502 DOI: 10.1038/bmt.2009.322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
96 Peters C. The EBMT Paediatric Diseases Working Party: current concepts and future aims. memo 2009;2:178-181. [DOI: 10.1007/s12254-009-0146-2] [Reference Citation Analysis]
97 Rzepecki P, Barzal J, Oborska S. Blood and marrow transplantation and nutritional support. Support Care Cancer 2010;18 Suppl 2:S57-65. [PMID: 19727844 DOI: 10.1007/s00520-009-0730-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
98 Tempescul A, Ianotto JC, Hardy E, Quivoron F, Petrov L, Berthou C. Peripheral blood stem cell collection in elderly patients. Ann Hematol 2010;89:317-21. [PMID: 19693499 DOI: 10.1007/s00277-009-0812-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
99 Ricardi U, Filippi AR, Biasin E, Ciammella P, Botticella A, Franco P, Corrias A, Vassallo E, Ragona R, Fagioli F. Late Toxicity in Children Undergoing Hematopoietic Stem Cell Transplantation with TBI-containing Conditioning Regimens for Hematological Malignancies. Strahlenther Onkol 2009;185:17-20. [DOI: 10.1007/s00066-009-1008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
100 Peinemann F, Grouven U, Kröger N, Pittler M, Zschorlich B, Lange S. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review. Haematologica 2009;94:1732-42. [PMID: 19648165 DOI: 10.3324/haematol.2009.007583] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
101 Andersson I, Hjermstad M, Stockelberg D, Persson LO. Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19). Acta Oncol 2008;47:275-85. [PMID: 18210301 DOI: 10.1080/02841860701558799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
102 Saccardi R, Gualandi F. Hematopoietic stem cell transplantation procedures. Autoimmunity 2009;41:570-6. [DOI: 10.1080/08916930802197776] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
103 Gratwohl A. Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases. Autoimmunity 2009;41:673-8. [DOI: 10.1080/08916930802197677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
104 Ljungman P, Bregni M, Brune M, Cornelissen J, Witte TD, Dini G, Einsele H, Gaspar HB, Gratwohl A, Passweg J, Peters C, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A, Velardi A, Niederwieser D; for the European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010;45:219-34. [DOI: 10.1038/bmt.2009.141] [Cited by in Crossref: 225] [Cited by in F6Publishing: 241] [Article Influence: 16.1] [Reference Citation Analysis]
105 Martínez C, Salamero O, Arenillas L, Duque J, López-guillermo A, Rovira M, Urbano-ispízua Á, Fernández-avilés F, Carreras E, Montserrat E. Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: Long-term outcome of 61 patients from a single institution. Leukemia & Lymphoma 2009;48:1968-75. [DOI: 10.1080/10428190701573265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
106 Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Escolar G, Eissner G, Holler E, Carreras E. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. Biol Blood Marrow Transplant 2009;15:537-46. [PMID: 19361745 DOI: 10.1016/j.bbmt.2009.01.013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
107 Paillard C, Salmon A, Curtillet C, David A, Halle P, Cachin F, Bordigoni P, Michel G, Rousseau R, Dore E, Isfan F, Merlin E, Rochette E, Demeocq F, Kanold J. Evidence of a clinical response at one yr after reduced-intensity allogeneic hematopoietic stem cell transplantation in heavily pretreated adolescents with aggressive refractory Hodgkin's lymphoma. Pediatr Transplant 2010;14:109-14. [PMID: 19490483 DOI: 10.1111/j.1399-3046.2009.01140.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
108 Schmit-pokorny K. Expanding Indications for Stem Cell Transplantation. Seminars in Oncology Nursing 2009;25:105-14. [DOI: 10.1016/j.soncn.2009.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
109 Ciceri F, Bonini C, Stanghellini MTL, Bondanza A, Traversari C, Salomoni M, Turchetto L, Colombi S, Bernardi M, Peccatori J, Pescarollo A, Servida P, Magnani Z, Perna SK, Valtolina V, Crippa F, Callegaro L, Spoldi E, Crocchiolo R, Fleischhauer K, Ponzoni M, Vago L, Rossini S, Santoro A, Todisco E, Apperley J, Olavarria E, Slavin S, Weissinger EM, Ganser A, Stadler M, Yannaki E, Fassas A, Anagnostopoulos A, Bregni M, Stampino CG, Bruzzi P, Bordignon C. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study. The Lancet Oncology 2009;10:489-500. [DOI: 10.1016/s1470-2045(09)70074-9] [Cited by in Crossref: 376] [Cited by in F6Publishing: 401] [Article Influence: 26.9] [Reference Citation Analysis]
110 Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S, Sacchi N, Sormani MP, Fanin R, Bandini G, Bonifazi F, Bosi A, Rambaldi A, Alessandrino PE, Falda M, Bacigalupo A. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant 2009;44:571-7. [DOI: 10.1038/bmt.2009.67] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
111 De Palma M, Naldini L. Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? Biochim Biophys Acta 2009;1796:5-10. [PMID: 19362584 DOI: 10.1016/j.bbcan.2009.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
112 Hazar V, Gungor O, Guven AG, Aydin F, Akbas H, Gungor F, Tezcan G, Akman S, Yesilipek A. Renal function after hematopoietic stem cell transplantation in children: Renal Function and Stem Cell Transplantation. Pediatr Blood Cancer 2009;53:197-202. [DOI: 10.1002/pbc.22030] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
113 Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics 2009;12:233-44. [PMID: 19367091 DOI: 10.1159/000203779] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
114 Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy., European Group for Blood and Marrow Transplantation. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009;43:275-91. [PMID: 19169283 DOI: 10.1038/bmt.2009.7] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.5] [Reference Citation Analysis]
115 Isbister JP. Haematological malignancies. Oh's Intensive Care Manual 2009. [DOI: 10.1016/b978-0-7020-3096-3.00092-0] [Reference Citation Analysis]
116 Kulkarni S, Treleaven J. Patient selection: preliminary interview, screening of patient and donor. Hematopoietic Stem Cell Transplantation in Clinical Practice 2009. [DOI: 10.1016/b978-0-443-10147-2.50024-2] [Reference Citation Analysis]
117 Hollands P. Cord Blood Stem Cells – The Basic Science. In: Stubblefield P, Bhattacharya N, editors. Frontiers of Cord Blood Science. London: Springer; 2009. pp. 19-25. [DOI: 10.1007/978-1-84800-167-1_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
118 Morra E, Barosi G, Bosi A, Ferrara F, Locatelli F, Marchetti M, Martinelli G, Mecucci C, Vignetti M, Tura S. Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation. Haematologica 2009;94:102-12. [PMID: 19001282 DOI: 10.3324/haematol.13166] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
119 Márquez Malaver F, Espigado Tocino I, Balsalobre López P, Carmona González M, Parody Ruiz-berdejo R, Perez-hurtado de Mendoza J, Urbano Ispizua A. Evaluation of the Pretransplantation Phase of the Hemopoietic Stem Cell Program in a Tertiary Hospital. Transplantation Proceedings 2008;40:3099-101. [DOI: 10.1016/j.transproceed.2008.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Kanold J, Paillard C, Tchirkov A, Merlin E, Marabelle A, Lutz P, Rousseau R, Baldomero H, Deméocq F. Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model. Bone Marrow Transplant 2008;42:S25-30. [DOI: 10.1038/bmt.2008.279] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
121 Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy ISCT., European Group for Blood and Marrow Transplantation EMBT (JACIE). Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant 2008;42 Suppl 1:S7-S10. [PMID: 18724308 DOI: 10.1038/bmt.2008.104] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
122 Karen Lin K, Sirin O, Goodell M. Hematopoietic Progenitor Cells. Gene and Cell Therapy 2008. [DOI: 10.1201/9780849387999.pt4] [Reference Citation Analysis]
123 De Palma M, Mazzieri R, Politi LS, Pucci F, Zonari E, Sitia G, Mazzoleni S, Moi D, Venneri MA, Indraccolo S, Falini A, Guidotti LG, Galli R, Naldini L. Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis. Cancer Cell 2008;14:299-311. [DOI: 10.1016/j.ccr.2008.09.004] [Cited by in Crossref: 206] [Cited by in F6Publishing: 214] [Article Influence: 13.7] [Reference Citation Analysis]
124 Zander AR, Bacher U, Finke J. Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification. Dtsch Arztebl Int 2008;105:663-9. [PMID: 19626214 DOI: 10.3238/arztebl.2008.0663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
125 Schetelig J, Bornhäuser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H, Stelljes M, Hegenbart U, Schäfer-Eckart K, Füssel M, Wiedemann B, Thiede C, Kienast J, Baurmann H, Ganser A, Kolb HJ, Ehninger G. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol 2008;26:5183-91. [PMID: 18768435 DOI: 10.1200/JCO.2007.15.5184] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 8.1] [Reference Citation Analysis]
126 Lee J, Kim C. The activity of hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2008;42:S92-5. [DOI: 10.1038/bmt.2008.127] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
127 Ciceri F, Labopin M, Aversa F, Rowe JM, Bunjes D, Lewalle P, Nagler A, Di Bartolomeo P, Lacerda JF, Lupo Stanghellini MT. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood. 2008;112:3574-3581. [PMID: 18606875 DOI: 10.1182/blood-2008-02-140095] [Cited by in Crossref: 225] [Cited by in F6Publishing: 242] [Article Influence: 15.0] [Reference Citation Analysis]
128 Wachowiak J, Labopin M, Miano M, Chybicka A, Stary J, Sterba J, Masszi T, Labar B, Maschan A, Kowalczyk JR, Lange A, Holowiecki J, Kalman N, Afanassiev BV, Dini G; on behalf of the EBMT Paediatric Working Party. Haematopoietic stem cell transplantation in children in eastern European countries 1985–2004: development, recent activity and role of the EBMT/ESH Outreach Programme. Bone Marrow Transplant 2008;41:S112-7. [DOI: 10.1038/bmt.2008.68] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
129 Rodriguez-Abreu D, Filho VB, Zucca E. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review. Hematol Oncol 2008;26:8-20. [PMID: 18050364 DOI: 10.1002/hon.836] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
130 Austin EB, Guttridge M, Pamphilon D, Watt SM. The role of blood services and regulatory bodies in stem cell transplantation. Vox Sang 2008;94:6-17. [PMID: 18171327 DOI: 10.1111/j.1423-0410.2007.00974.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
131 Craig CM, Schiller GJ. Acute myeloid leukemia in the elderly: conventional and novel treatment approaches. Blood Rev 2008;22:221-34. [PMID: 18433953 DOI: 10.1016/j.blre.2008.03.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
132 Giancola R, Olioso P, Di Riti M, Capone A, Contento A, Pompetti F, Iacone A. Evaluation of an automated closed fluid management device for processing expanded cytokine-induced killer cells to use in immunotherapy programs for cancer. Transfusion 2008;48:629-39. [DOI: 10.1111/j.1537-2995.2007.01587.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
133 Jagannathan JP, Ramaiya N, Gill RR, Alyea EP, Ros P. Imaging of Complications of Hematopoietic Stem Cell Transplantation. Radiologic Clinics of North America 2008;46:397-417. [DOI: 10.1016/j.rcl.2008.04.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
134 Matthes-martin S, Pötschger U, Bergmann K, Frommlet F, Brannath W, Bauer P, Klingebiel T. Risk-Adjusted Outcome Measurement in Pediatric Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2008;14:335-43. [DOI: 10.1016/j.bbmt.2007.12.487] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
135 Baum C, Schambach A, Modlich U, Thrasher A. [Gene therapy of SCID-X1]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007;50:1507-17. [PMID: 18046520 DOI: 10.1007/s00103-007-0385-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
136 Arpaci F, Tezcan I, Kuzhan O, Yalman N, Uckan D, Kürekci AE, Ikincioğullari A, Ozet A, Tanyeli A. G-CSF-mobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders. Am J Hematol 2008;83:133-6. [PMID: 17722073 DOI: 10.1002/ajh.21017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
137 Sierra J, Martino R, Sánchez B, Piñana JL, Valcárcel D, Brunet S. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia. Bone Marrow Transplant 2008;41:425-37. [PMID: 18209727 DOI: 10.1038/sj.bmt.1705973] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
138 Duarte RF, Schmitz N, Servitje O, Sureda A. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma. Bone Marrow Transplant. 2008;41:597-604. [PMID: 18176611 DOI: 10.1038/sj.bmt.1705968] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 6.0] [Reference Citation Analysis]
139 Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT)., European Group for Blood and Marrow Transplantation EBMT (JACIE). The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant 2008;41:687-705. [PMID: 18084334 DOI: 10.1038/sj.bmt.1705956] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
140 Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, Hunter AE, Kanz L, Slavin S, Cornelissen JJ, Gramatzki M, Niederwieser D, Russell NH, Schmitz N. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008;26:455-62. [PMID: 18086796 DOI: 10.1200/JCO.2007.13.2415] [Cited by in Crossref: 240] [Cited by in F6Publishing: 257] [Article Influence: 15.0] [Reference Citation Analysis]
141 Sureda A. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007;21:943-60. [PMID: 17908630 DOI: 10.1016/j.hoc.2007.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
142 Hoy SM, Lyseng-Williamson KA. Intravenous busulfan: in the conditioning treatment of pediatric patients prior to hematopoietic stem cell transplantation. Paediatr Drugs 2007;9:271-8. [PMID: 17705566 DOI: 10.2165/00148581-200709040-00008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
143 Naumann F, Kruse E, Weingart O, Bohlius J, Hübel K, Herrmann-frank A, Skipka G, Engert A. Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia. Cochrane Database of Systematic Reviews 2007. [DOI: 10.1002/14651858.cd006835] [Reference Citation Analysis]
144 Tan SS, Uyl-de Groot CA, Huijgens PC, Fibbe WE. Stem cell transplantation in Europe: trends and prospects. Eur J Cancer 2007;43:2359-65. [PMID: 17919900 DOI: 10.1016/j.ejca.2007.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
145 Dreger P, Brand R, Michallet M. Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia. Seminars in Hematology 2007;44:246-51. [DOI: 10.1053/j.seminhematol.2007.08.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
146 Feve F, Cambon-Thomsen A, Eliaou JF, Gourraud PA, Raffoux C, Florens JP. [Economic evaluation of the organization of a registry of haematopoietic stem cell donors]. Rev Epidemiol Sante Publique 2007;55:275-84. [PMID: 17597327 DOI: 10.1016/j.respe.2007.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
147 Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D, de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007;47:1268-75. [PMID: 17581163 DOI: 10.1111/j.1537-2995.2007.01267.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
148 Gratwohl A, Baldomero H. I05 Hematopoietic stem cell transplantation in Europe Economical and political implications. Blood Reviews 2007;21:S13-S22. [DOI: 10.1016/s0268-960x(07)70006-1] [Reference Citation Analysis]
149 Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy ISCT., European Group for Blood and Marrow Transplantation EBMT. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007;39:71-87. [PMID: 17213849 DOI: 10.1038/sj.bmt.1705555] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 5.3] [Reference Citation Analysis]
150 Chaidos A, Kanfer E, Apperley JF. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage. Best Pract Res Clin Haematol 2007;20:125-54. [PMID: 17448953 DOI: 10.1016/j.beha.2006.10.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
151 Smythe J, Armitage S, McDonald D, Pamphilon D, Guttridge M, Brown J, Green A, Brown C, Warwick RM, Lankester A, Fehily D, Contreras M, Navarrete C, Watt SM. Directed sibling cord blood banking for transplantation: the 10-year experience in the national blood service in England. Stem Cells 2007;25:2087-93. [PMID: 17510215 DOI: 10.1634/stemcells.2007-0063] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
152 Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Urbano-Ispizua A, Frauendorfer K. Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations. Leukemia 2007;21:383-6. [PMID: 17311065 DOI: 10.1038/sj.leu.2404509] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
153 Nydegger UE, Riedler GF, Flegel WA. Histoblood groups other than HLA in organ transplantation. Transplant Proc 2007;39:64-8. [PMID: 17275475 DOI: 10.1016/j.transproceed.2006.10.222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
154 Kruse E, Naumann F, Schwarzer G, Borchmann P, Peinemann F, Bohlius J, Engert A. First-line stem cell transplantation from related donors compared to immunosuppressive treatment for acquired severe aplastic anaemia. Cochrane Database of Systematic Reviews 2007. [DOI: 10.1002/14651858.cd006407] [Reference Citation Analysis]
155 Miano M, Labopin M, Hartmann O, Angelucci E, Cornish J, Gluckman E, Locatelli F, Fischer A, Egeler RM, Or R, Peters C, Ortega J, Veys P, Bordigoni P, Iori AP, Niethammer D, Rocha V, Dini G; for the Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2007;39:89-99. [DOI: 10.1038/sj.bmt.1705550] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 5.3] [Reference Citation Analysis]
156 Viola A, Falco C, D'elia R, D'amico MR, Vicari L, Tambaro FP, Correale P, Laudati D, Palmieri S, Ferrara F. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia. Eur J Haematol 2007;78:41-7. [DOI: 10.1111/j.1600-0609.2006.00777.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
157 Ferrara F, Viola A, Copia C, Falco C, D'elia R, Tambaro FP, Correale P, D'amico MR, Vicari L, Palmieri S. Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia. Hematol Oncol 2007;25:84-9. [DOI: 10.1002/hon.810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
158 Rubio-terrés C, Codina JG, Cercós AC, Roma E, Tisaire JL. Impacto presupuestario del tratamiento en segunda línea de los pacientes con linfoma folicular en recaída o refractario a rituximab, con 90Y-ibritumomab tiuxetan en lugar de los tratamientos habituales. Pharmacoecon Span Res Artic 2007;4:3-10. [DOI: 10.1007/bf03323426] [Reference Citation Analysis]
159 Fernández-avilés F, Carreras E, Urbano-ispizua A, Rovira M, Martínez C, Gaya A, Granell M, Ramiro L, Gallego C, Hernando A, Segura S, García L, González M, Valverde M, Montserrat E. Case-Control Comparison of At-Home to Total Hospital Care for Autologous Stem-Cell Transplantation for Hematologic Malignancies. JCO 2006;24:4855-61. [DOI: 10.1200/jco.2006.06.4238] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
160 Jantunen E. Autologous stem cell transplantation beyond 60 years of age. Bone Marrow Transplant 2006;38:715-20. [PMID: 17041609 DOI: 10.1038/sj.bmt.1705514] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
161 Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A; Joint Accreditation Committee, International Society for Cellular Therapy., European Group for Blood and Marrow Transplantation. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 2006;37:1069-85. [PMID: 16757972 DOI: 10.1038/sj.bmt.1705377] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 4.6] [Reference Citation Analysis]
162 Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R, Halter J, Helg C, Chapuis B, Gratwohl A, Tichelli A, Nicoloso de Faveri G, Roosnek E, Passweg JR; Swiss Transplant Working Group for Blood and Marrow Transplantation (STABMT)., Swiss National Donor Registry. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant 2006;37:909-16. [PMID: 16565739 DOI: 10.1038/sj.bmt.1705353] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]